Given that the majority of cancer cells are of epithelial cell origin and Ephexin4 is overexpressed in various cancer cells, inhibition of the signaling pathway for Ser41 phosphorylation of Ephexin4 may represent a candidate target for developing novel cancer drugs. The gene discussed is ARHGEF16; the disease is cancer.